Rybo is creating breakthroughs in gene therapy, as well as in treating cancer, autoimmune diseases and HIV.
Rybo is developing tools for efficient Synthetic mRNA translation.
Among Rybo’s initiatives includes researching potential DNA augmentations to inspire the automatic production of Synthetic mRNA translation factors
Beyond translation factors, Rybo is seeking to treat immunogenicity without compromising overall immunity.
Beyond a synthetic siRNA mediated repression solution, we are creating a feedback mechanism through the Synthetic mRNA itself, where effective translation continuously treats a specific immune response.
Rybo is even applying its methods in creating a more Sustainable Agriculture!
Apply to join a project like this one and receive:
